Affordable Access

Publisher Website

Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C

Authors
Journal
Hepatitis Monthly
1735-143X
Publisher
Kowsar Medical Institute
Publication Date
Volume
13
Issue
5
Identifiers
DOI: 10.5812/hepatmon.8962
Source
legacy-msw
Keywords
  • Letter
Disciplines
  • Medicine

Abstract

Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C Reza Karbasi-Afshar 1 , Amin Saburi 2, 3, * 1 Cardiovascular Diseases Department, Baqiyatallah University of Medical Sciences, Tehran, IR Iran 2 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran 3 Baqiyatallah Research Center of Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran *Corresponding author: Amin Saburi, Chemical Injuries Research Center and Baqiyatallah Research Center of Gastroenterology and Liver diseases (BRCGL), Baqiyatallah University of Medical Sciences, Mollasadra St, Vanak Sq, Tehran, IR Iran. Tel/Fax: +98-2188600067, E-mail: [email protected], saburi@ brcgl.com. Keywords: Hepatitis C; Interferon-Gamma; Ribavirin; Combined Modality Therapy Article type: Letter; Received: 05 Nov 2012; Accepted: 17 Dec 2012; Epub: 14 May 2013 Please cite this paper as: Karbasi-Afshar R, Saburi A. Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C. Hepat Mon. 2013;13(5):e8962. DOI: 10.5812/hepatmon.8962 Copyright © 2013, Kowsar Corp.; Published by Kowsar Corp. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which per- mits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Dear Editor, We read with great interest the recently published arti- cle by Almawardy et al entitled “Is Combination Therapy for Chronic Hepatitis C Toxic for Cardiac Function?” (1). They skillfully evaluated 120 cases with hepatitis C virus infections treated with a combination protocol consist- ing interferon gamma (INFg) a or b in addition to Riba- virin and their aimed to evaluate cardiac toxicity of this regiment during six months treatment. They finally con- cluded that “combination therapy does n

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

[Antiviral combination therapy in chronic hepatiti...

on Nederlands tijdschrift voor ge... Jul 11, 1987

Combination therapy for chronic hepatitis C.

on Italian journal of gastroenter... March 1999
More articles like this..